Want to join the conversation?
Global pharmaceutical company $AGN acquired $KYTH in an all-cash transaction valued at approx. $2.1Bil. This deal adds KYBELLA (deoxycholic acid) injection for treatment of double-chin in adults and $KYTH's development product setipiprant (KYTH-105), a novel compound for the prevention of androgenetic alopecia to the $AGN's portfolio of offerings.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.